why choose us

First received: February 24, 2023

Clinical Trial: Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial

Study Status: Completed

Recruit Status: RECRUITING

Condition: Sepsis

Study Type: INTERVENTIONAL


Official Title: Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial

Brief Summary: The long-term goal is to test the clinical efficacy of senolytic therapies to reduce progression to and severity of sepsis in older patients.The central hypothesis is that a threshold burden of SnCs predisposes to a SASP mediated dysfunctional response to PAMPs, contributing to a disproportionate burden of sepsis in older patients.The study hypothesizes timely treatment with fisetin will interrupt this pathway.A multicenter, randomized, adaptive allocation clinical trial to identify the most efficacious dose of…

Read more